Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_assertion type Assertion NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_head.
- NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_assertion description "[As a result of its potential role in the selection of therapy, HER-2/neu testing has reached near-standard-of-practice status in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_provenance.
- NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_assertion evidence source_evidence_literature NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_provenance.
- NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_assertion SIO_000772 11458821 NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_provenance.
- NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_assertion wasDerivedFrom befree-2016 NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_provenance.
- NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_assertion wasGeneratedBy ECO_0000203 NP324248.RAB1BhzMIhpFaZrT_TycEIYWq2q24xjpPWEU4UmisVuFE130_provenance.